Help
RSS
API
Feed
Maltego
Contact
Domain > www.herceptinhylecta-hcp.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-08-31
104.18.30.212
(
ClassC
)
2025-01-08
104.18.31.212
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Sat, 31 Aug 2024 22:08:21 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Sat, 31 Aug 2024 23:08:21 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sat, 31 Aug 2024 22:08:21 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-alivevary: Accept-EncodingCF-Cache-Status: DYNAMICSet-Cookie: __cfruid !DOCTYPE HTML>html langen-US> head> meta charsetUTF-8/> title>Herceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk | HER2-Positive Breast Cancer Treatment/title> meta namedescription contentLearn about Herceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk), a subcutaneous injection for eligible patients with HER2-positive breast cancer. See Full Safety and BOXED WARNINGS for more information./> meta nametemplate contentflexible-page/> meta nameviewport contentwidthdevice-width, initial-scale1/> link relcanonical hrefhttps://www.herceptinhylecta-hcp.com//> meta propertyog:site_name contentherceptinhylecta/> meta propertyog:type contentwebsite/> meta propertyog:locale contenten_US/> meta propertyog:title contentHerceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk | HER2-Positive Breast Cancer Treatment/> meta propertyog:description contentLearn about Herceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk), a subcutaneous injection for eligible patients with HER2-positive breast cancer. See Full Safety and BOXED WARNINGS for more information./> meta propertyog:url contenthttps://www.herceptinhylecta-hcp.com//> meta propertyog:image contenthttps://www.herceptinhylecta-hcp.com/content/dam/gene/herceptinhylecta-hcp/global/Herceptin_HYLECTA_Logo.genecoreimg.1200.png/> meta propertyog:image:type contentimage/png/> meta propertyog:image:width content1200/> meta propertyog:image:height content239/> meta propertyog:image:alt contentHerceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk) injection for subcutaneous use/> meta nametwitter:card contentsummary_large_image/> meta namepub_date content2023-03-30T14:42:43-0700/> link relicon typeimage/x-icon href/content/dam/gene/herceptinhylecta-hcp/global/favicon.png/> link relshortcut icon typeimage/x-icon href/content/dam/gene/herceptinhylecta-hcp/global/favicon.png/> link hrefhttps://fonts.googleapis.com/css2?familyOpen+Sans:ital,wght@0,400;0,700;1,400;1,700&displ
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]